Monograph Details
|
|
Nutrition
> Electrolyte disturbances
|
|
KLOR-CON M |
| Manufacturer |
|
Upsher-Smith Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Potassium (as chloride) 10mEq, 15mEq+, 20mEq+; ext-rel tabs (+scored). |
| Also |
• KLOR-CON
• KLOR-CON/EF
• KLOR-CON POWDER
|
| Indications |
|
Hypokalemia, including that caused by diuretics. Digitalis intoxication without AV block. |
| Children |
|
Not recommended. |
| Adults |
|
Take with meals and fluids. Swallow tabs whole; may break Klor-Con M tabs in half, or mix in 4oz water. Effervescent tabs, pwd: dissolve in beverage. Prophylaxis: 20mEq daily. Treatment: 40–100mEq daily in divided doses; max 20mEq/dose. |
| Contraindications |
|
Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis (potassium chloride products). Alkalosis (potassium bicarbonate products). Tablets: Esophageal compression due to enlarged left atrium. Decreased GI motility. |
| Precautions |
|
Discontinue if GI bleed, ulceration, or other disturbances occur. Renal or cardiac disease. Monitor potassium level, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Hyperkalemia with ACE inhibitors, spironolactone, triamterene, amiloride, and potassium-containing salt substitutes. Anticholinergics, other agents that decrease GI motility increase risk of serious GI reactions with tablets. |
| Adverse Reactions |
|
Hyperkalemia, GI discomfort and irritation, diarrhea, rash (rare). Tablets: Esophageal and GI ulceration, bleeding, obstruction, perforation. |
| How Supplied |
M10—90, 100, 1000
M15—100, 1000
M20—90, 100, 500, 1000
Klor-Con 8, 10—100, 500
Pwd (20mEq packets)—30, 100
Pwd (25mEq packets)—30, 100, 250
Klor-Con/EF—30, 100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
